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Abstract: In recent years, dry eye has become a hot topic within ophthalmology and optometry, especially in regards to new frontiers in
treatment modalities which include novel devices, procedures, and medications. However, some of the more understudied areas in dry
eye involve its impact on quality of life. Although ocular discomfort symptoms are well known to be associated with dry eye, its negative
effects on visual function remain underrecognized. This paper reviews these topics within the currently published literature to heighten
awareness among clinicians.
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1. Introduction
Among all ocular conditions, dry eye remains one of the
most prevalent in clinical practice, ranging from 5% to 50%
with higher variations in signs than symptoms [1]. Increased
age, female sex, and Asian ethnicity are among the most
consistent risk factors for developing dry eye disease [1].
In fact, the various signs and symptoms of dry eye often
prompt patients to seek eye care due to its widespread affect
on day to day life.
Currently, the most broadly accepted definition of
dry eye disease revolves around the Tear Film and Ocular
Surface Society International Dry Eye Workshop (TFOS
DEWS II) in 2017 as a “multifactorial disease of the ocular
surface characterized by a loss of homeostasis of the tear film,
and accompanied by ocular symptoms, in which tear film
instability and hyperosmolarity, ocular surface inflammation
and damage, and neurosensory abnormalities play etiological
roles.” [1] The vast complexities of pathophysiology,
immunology, epidemiology, genetics, mechanisms of action,
diagnosis, and treatment/management approaches continue
to be extensively investigated and researched worldwide.
We will herein emphasize the negative effects of dry eye on
quality of life, particularly as it relates to visual symptoms
commonly reported by the afflicted patients.
2. Dry eye and quality of life
The World Health Organization recognizes quality of life
to be a multifaceted concept incorporating how health

conditions can alter (1) physical health, (2) psychological
wellbeing, (3) level of independence, (4) environmental
impact, (5) social relationships, and (6) spirituality/
religion/personal beliefs [2].
Among these quality of life categories, dry eye most
directly affects the first four [2]:
2.1. Physical health
- Pain and discomfort: Dry eye patients will frequently
complain of varying forms of ocular pain and discomfort
including sharpness, dullness, stinging, burning, pressure
sensation, throbbing, foreign body sensation, sandiness,
grittiness, redness, tearing/watering, stringy mucous
discharge, eye strain, eye fatigue, heavy eyelids, contact
lens intolerance, and light sensitivity [3,4,8].
- Blurred vision: Inadequate tear production and/
or poor quality tears characteristic to dry eye disease
can cause intermittent blurred or fluctuating vision. In
addition, glare or haloes around lights at night [3] can also
result due to poor tear film quality.
- Poor sleep quality: A 2016 study implementing
the Pittsburgh sleep quality index found that among 672
participants ages 26–64, poor sleep quality was associated
with dry eye disease[5].
2.2. Psychological
- Bodily image, appearance, self esteem, negative
feelings: Dry eye is often associated with chronic red
hyperemic eyes, especially those suffering from redness
associated with ocular rosacea[6]. Physical appearance of
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redness can negatively influence emotional health leading
to comorbid anxiety disorders and social phobias[6]. In
fact, a 2016 large population systemic review and metaanalysis study found that depression and anxiety are more
prevalent among patients suffering from dry eye disease,
specifically those dry eye patients afflicted with primary
Sjögren’s syndrome who were found to have the highest
prevalence and severity of depression[7].
- Thinking, learning, memory, concentration: Studies
on chronic pain syndromes similar to dry eye might
explain how it can negatively affect cognitive processes,
sleep, mood, and mental health [4,7]. Chronic dry eye also
causes fluctuating vision which can slow reading rates and
significantly disrupt day to day tasks that require visual
concentration for long periods of time [8].
2.3. Level of independence
- Activities of daily living: Because dry eye is a chronic
incurable condition, both palliative and medicinal
management can be lifelong, creating the added burden
of integrating dry eye treatment regimens with activities
of daily living. Studies support that patients who are older,
have poor vision, or have limited schooling struggle the
most with adhering to dry eye treatment compliance
[9–12]. Furthermore, patients with poor manual dexterity
secondary to neurodegenerative and autoimmune
pathology (dementia [11], Parkinson’s, multiple sclerosis,
rheumatoid arthritis, etc) may also experience limited
independence from being unable to handle eye drop
instillations themselves.
- Dependence on medicinal substances and
medical aids: Longterm management of dry eye
symptomatology includes topical immunomodulators,
topical corticosteroids, artificial tears/gels/ointments,
eyelid/eyelash cleansers, punctal plugs, omega-3 fatty acid
supplements, antibiotics (topical and systemic), moisture
goggles, and autologous serum tears [4].
- Work capacity: Many published works support dry
eye disease to have negative effects on concentration [7,8]
and decreased productivity [1,13,14]. More specifically,
studies found dry eye to reduce workplace [13,14] and
nonjob related [13] performances and create substantial
loss to work industry [14].
2.4. Environmental impact
- Financial resources: The economic burden of long-term
dry eye management can be significant, including the costs
of medical eye office visits, medications, and dietary or
palliative supplements. In fact, a 2011 survey study among
2,171 dry eye patients found the average annual cost to be
$783 with an overall burden of dry eye disease for the U.S.
healthcare system to be an estimated $3.84 billion [15].
Furthermore, costs are higher among patients suffering
from moderate to severe forms of dry eye disease [15].
- Participation in and opportunities for recreation/
leisure: Dry eye disease can negatively affect nonjob
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related [13] activities including sports where fluctuating
visual acuity due to poor tear film dynamics can
compromise one’s accuracy of visual tracking and fixation
ability on moving targets whilst incorporating hand eye
coordination.
- Physical environment (pollution/noise/traffic/
climate): Multiple external and environmental risk factors
can exacerbate dry eye disease, especially air pollutants.
More specifically, O3, PM2.5, and SO2 were associated with
dry eye disease according to a 2019 large population study
in China[16].
3. Quality of life assessment and patient questionnaires
In recent years, various self-reported outcome measure
questionnaires have been created to assess dry eye
symptoms and how they impact various aspects of quality
of life. We will review five major questionnaires commonly
utilized across eye clinics and academic centers as primary
means to assess symptomatology and effects on quality of
life.
3.1. Ocular surface disease index (OSDI):
Twelve patient response items in a points summation
system assesses symptoms, functional limitations, and
environmental factors related to dry eye[17,18]. Three
subsections account for vision-related function, dry eye
symptoms, and environmental triggers[18]. The OSDI is
among the most commonly utilized survey questionnaires
utilized to assess ocular surface disease severity in dry
eye research[17,18] including patients with Sjögren’s
syndrome[19], glaucoma [20], and Graves’ disease[21].
Most importantly, the OSDI has been implemented to
assess the efficacy of various dry eye treatments[22–24].
One major drawback to the OSDI is its limited account on
the effects of dry eye disease on vision-related functioning
as opposed to severity alone; therefore it is less likely to
describe the full impact and burden of dry eye on everyday
life compared to other comprehensive questionnaires like
the impact of dry eye on everyday life (IDEEL) [25] and
the National Eye Institute’s visual function questionnaire
(NEI VFQ-25). Overall however, OSDI has proven
to be a valuable patient reported outcome measure in
ophthalmology research and clinical trials[26].
3.2. Standard patient evaluation of eye dryness (SPEED):
Similar to OSDI, SPEED also utilizes twelve patient
response items in a points summation system. However
unlike OSDI, the three subsections in SPEED solely focus
on symptoms: type, frequency, and severity. Studies found
while both OSDI and SPEED are suitable for detecting dry
eye symptoms, their results cannot be used interchangeably
because SPEED correlated more with evaporative dry eye
while OSDI correlated more with aqueous tear-deficient
dry eye [27]. Certain studies support SPEED being
superior to OSDI in differentiating between asymptomatic
vs symptomatic patients [28]. Overall, SPEED has been
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shown to be repeatable and valid instrument for measuring
dry eye symptoms correlating significantly with ocular
surface staining and clinical measures of Meibomian gland
dysfunction [29].
3.3. Symptom assessment questionnaire in dry eye
(SANDE):
Unlike OSDI, the SANDE is a more simplified questionnaire
utilizing a two-questioned 100 mm horizontal linear visual
analog scale, quantifying both severity and frequency of dry
eye symptoms. A 2015 study demonstrated that SANDE
had significant correlation and negligible score differences
to OSDI implying its potential to provide shorter, quicker,
and comparably reliable measures of dry eye symptoms
to that of OSDI [30]. Recent 2019 studies found that both
OSDI and SANDE have superior discriminative ability in
detecting dry eye signs compared to other questionnaires
including SPEED [31]. SANDE has also been utilized to
assess the efficacy of certain dry eye treatments including
the new TearCare system [32]. While its simplicity certainly
improves efficiency in everyday clinical practice for general
dry eye screening purposes, SANDE’s less detailed nature
limits its ability to cover the breadth of information
required to better assess dry eye effects on quality of life.
3.4. Impact of dry eye on everyday life (IDEEL):
Unlike other questionnaires, the IDEEL is lengthy and more
comprehensive, involving three modules and 57 questions
that assess (1) dry eye symptoms and severity, (2) dry eye’s
impact on quality of life including daily activities, emotional
feelings, and work/productivity, and (3) treatment
satisfaction [25,26]. Studies have found that IDEEL better
discriminates dry eye severity levels than other quality of
life scales [33]. While the main drawback of IDEEL is the
glaring inefficiency (approximately 30 min to complete), it
meets the new FDA patient reported outcome instrument
guidelines and aligns with validity and reliability standards
[25]. Furthermore, IDEEL contains the most quality of life
measures of any current dry eye questionnaire [26].
3.5. National Eye Institute’s visual function questionnaire
(NEI VFQ-25):
This questionnaire focuses on visual function impairments
secondary not only to dry eye but other diseases including
cataracts, macular degeneration, diabetic retinopathy,
glaucoma, stroke-related vision loss, or low vision[34-41].
The 25-item approach includes several visual domains
(general, distance, near, peripheral, driving, color), ocular
pain scales, and five non-visual domains (general health,
mental health, dependency, social function, role limitations)
[9]. Overall, multiple studies continue to implement NEI
VFQ-25 as a valid cross-sectional measure of how various
diseases can impact visual function and quality of life.
4. Dry eye and visual function
Visual acuity represents the static measurement of image
sharpness/resolution on a focal plane in an optical system

(retina in the human eye). Visual function on the other
hand, has more to do with the broader concept of how well
visual acuity remains optimized in the setting of dynamic
day-to-day tasks. Image quality to the retina is dependent
on a clear light path through all ocular structures. The precorneal tear film is the first structure having direct influence
on the optical light path [42]. When dry eye disease is
present, the tear film is degraded often due to insufficient
tear secretion quantity (aqueous tear deficiency) and/or
poor tear film quality and stability leading to early break-up
(evaporative Meibomian gland dysfunction-related lipid
tear deficiency or inflammatory mucin tear deficiency) [43].
Functional visual acuity is a contrast measurement
of visual acuity during and after sustained visual activity,
which is argued to be more accurately representative of
visual function in real-life situations like reading, computer
work, and driving [9]. In fact, dry eye disease has been
found in multiple studies to degrade visual function with
sustained visual tasks like reading [8,44,45], digital device
use (computer vision syndrome) [46], and driving [47].
Furthermore, studies support that dry eye disease negatively
affects contrast sensitivity [48] and is associated with
irregular astigmatism and higher order optical aberrations
[49]. Dry eye causes increased straylight secondary to
unstable tear film and reduces contrast sensitivity due to
central superficial punctate keratopathy [50]. Therefore, a
consistently stable tear film is critical to maintaining image
quality in optimized visual functioning.
In conclusion, there continues to be growing evidence
in the literature that dry eye disease negatively impacts
quality of life and visual function across more domains
than healthcare providers may realize. This may explain
the paradigm shift in eye care now homing in on assessing
visual function as opposed to ocular discomfort symptoms
alone. While multiple questionnaires are currently available
to quantify the effects of dry eye in clinical practice, dry eye
diagnosis often remains missed during common clinical
testing. Improved standards in patient care will remain
dependent on doctors being more cognizant of how
significantly tear film pathology can negatively affect their
patient’s visual function day by day.
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